IO Biotech | 10-K/A: Annual report (Amendment)
IO Biotech | 4: Statement of changes in beneficial ownership of securities-Officer Zocca Mai-Britt
IO Biotech | 4: Statement of changes in beneficial ownership of securities-Officer Smith Devin Whittemore
IO Biotech | 4: Statement of changes in beneficial ownership of securities-Officer Sullivan Amy
IO Biotech | 4: Statement of changes in beneficial ownership of securities-Officer Burkavage Brian
IO Biotech | 4: Statement of changes in beneficial ownership of securities-Officer Ahmad Qasim Iftikhar
IO Biotech | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
IO Biotech | 10-K: Annual report
IO Biotech | 8-K: IO Biotech Announces 2023 Fourth-Quarter and Year-End Results
IO Biotech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avoro Capital Advisors LLC(0%),Behzad Aghazadeh(0%)
IO Biotech | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Novo Holdings A/S(11.1%)
IO Biotech | 4: Statement of changes in beneficial ownership of securities-10% Owner Novo Holdings A/S
IO Biotech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BANK OF AMERICA CORPORATION(2.8%)
IO Biotech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-HBM Healthcare Investments (Cayman) Ltd.(6.0%)
IO Biotech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
IO Biotech | 144: Notice of proposed sale of securities pursuant to Rule 144
IO Biotech | 8-K: Current report
IO Biotech | SC 13G: Statement of acquisition of beneficial ownership by individuals-Samsara BioCapital, L.P.(5.5%),Samsara BioCapital GP, LLC(5.5%), etc.
IO Biotech | 4: Statement of changes in beneficial ownership of securities-Chief Accounting Officer Burkavage Brian
IO Biotech | 4: Statement of changes in beneficial ownership of securities-Director Collins Helen Louise
No Data